NurExone Biologic Inc.
NRXBF
$0.50
-$0.0122-2.38%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -1.55M | -1.25M | -1.33M | -922.00K | -737.00K |
| Total Depreciation and Amortization | 39.00K | 18.00K | 13.00K | 15.00K | 3.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 333.00K | 316.00K | 320.00K | 24.00K | 200.00K |
| Change in Net Operating Assets | -561.00K | 98.00K | 122.00K | -582.00K | -99.00K |
| Cash from Operations | -1.74M | -818.00K | -870.00K | -1.47M | -633.00K |
| Capital Expenditure | -46.00K | -301.00K | -61.00K | -241.00K | -67.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.00K | 0.00 | -10.00K | -- | 23.00K |
| Cash from Investing | -45.00K | -301.00K | -71.00K | -241.00K | -44.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -7.00K | -8.00K | -7.00K | -8.00K | -8.00K |
| Issuance of Common Stock | 1.46M | 877.00K | 15.00K | 3.49M | 328.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.28M | 390.00K | 36.00K | 921.00K | -230.00K |
| Cash from Financing | 177.00K | 1.26M | 44.00K | 4.40M | 90.00K |
| Foreign Exchange rate Adjustments | -220.00K | -2.00K | 27.00K | 22.00K | -15.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.82M | 138.00K | -870.00K | 2.71M | -602.00K |